|
SCARB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.0864978895504E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.94709845205921E-11 |
| Normal-vs-Stage2 |
9.999200E-03 |
| Normal-vs-Stage3 |
2.28270000013353E-07 |
| Normal-vs-Stage4 |
2.18720000000339E-07 |
| Stage1-vs-Stage2 |
9.183900E-02 |
| Stage1-vs-Stage3 |
3.155800E-01 |
| Stage1-vs-Stage4 |
7.460400E-01 |
| Stage2-vs-Stage3 |
2.938800E-01 |
| Stage2-vs-Stage4 |
8.991500E-02 |
| Stage3-vs-Stage4 |
2.845800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.28099819219597E-11 |
| Normal-vs-AfricanAmerican |
6.42650000000078E-05 |
| Normal-vs-Asian |
1.63470000003052E-06 |
| Caucasian-vs-AfricanAmerican |
1.506210E-01 |
| Caucasian-vs-Asian |
5.518600E-01 |
| AfricanAmerican-vs-Asian |
3.986200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.18489999987059E-07 |
| Normal-vs-Female |
2.58270071995526E-11 |
| Male-vs-Female |
2.383200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.17149631609459E-11 |
| Normal-vs-Age(41-60Yrs) |
1.87759999770165E-08 |
| Normal-vs-Age(61-80Yrs) |
3.71590000000088E-05 |
| Normal-vs-Age(81-100Yrs) |
9.218200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.216300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.084100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.337700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.394200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.088970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.032000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.933800E-01 |
| Classical-VS-Follicular |
4.43400000049721E-08 |
| Classical-VS-Other |
3.266200E-01 |
| Classical-VS-Normal |
1.68220992691204E-12 |
| Tall-VS-Follicular |
1.781530E-03 |
| Tall-VS-Other |
4.655000E-01 |
| Tall-VS-Normal |
8.7406000004453E-07 |
| Follicular-VS-Other |
4.143600E-01 |
| Follicular-VS-Normal |
7.302200E-02 |
| Other-VS-Normal |
4.301800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.8395000003304E-07 |
| Normal-vs-N1 |
2.356000E-04 |
| N0-vs-N1 |
7.336400E-01 |
|
|
